In this article published in Medical Device News, Chris Dawson, Head of TTP's Biosensing team explores how CGM manufacturers can adapt to this growing market by:
- Designing flexible, user-friendly devices tailored to diverse needs
- Addressing adherence challenges with comfort, simplicity, and on-demand monitoring
- Supporting preventative health strategies with accessible, actionable insights
Read the article in Medical Device News to learn how evolving CGM hardware can better support Type 2 patients and set the standard for proactive diabetes management. Read the full article
About TTP’s Biosensing Team
Specialising in the development of wearable and implantable biosensors, TTP’s Biosensing product development team deploys multidisciplinary teams, combining expert capabilities from electrochemistry and optics to human factors, mechanical design, software, electronics, wireless power and communications to deliver tailored solutions that meet the most demanding project requirements.
Partnering with us means working with experts who understand the CGM industry inside out. Whether navigating uncharted territories, supporting your next innovation or accelerating time to market, we solve complex challenges with engineering and scientific rigour, finding and retiring risks early to deliver high-impact, human-centred results. When your internal bandwidth is constrained, TTP is ready to deliver. With deep expertise and a 25-year track record, we provide the agility and expertise needed to ensure your commercial success. Find out more.
Read more about how we are accelerating CGM device development.
